N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide

C19H29N5O2 — CID 176610112

IUPACN-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide
SMILESCC1=C(CC(=O)N[C@H](C)C2CCC(C#N)CN2)C(=O)NC2CCNCC12
InChIInChI=1S/C19H29N5O2/c1-11-14(19(26)24-17-5-6-21-10-15(11)17)7-18(25)23-12(2)16-4-3-13(8-20)9-22-16/h12-13,15-17,21-22H,3-7,9-10H2,1-2H3,(H,23,25)(H,24,26)/t12-,13?,15?,16?,17?/m1/s1
InChIKeyBIYASCUNSYMEMF-OBAOUDRSSA-N
MW359.47 g/mol
LogP0.20
Rot. Bonds4

About N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide

N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide (PubChem CID 176610112) has the molecular formula C19H29N5O2 and a molecular weight of 359.47 g/mol. Its IUPAC name is N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide.

Molecular Properties

Compound NameN-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide
PubChem CID176610112
Molecular FormulaC19H29N5O2
Molecular Weight359.47 g/mol
Exact Mass359.23
IUPAC NameN-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide
SMILESCC1=C(CC(=O)N[C@H](C)C2CCC(C#N)CN2)C(=O)NC2CCNCC12
InChIInChI=1S/C19H29N5O2/c1-11-14(19(26)24-17-5-6-21-10-15(11)17)7-18(25)23-12(2)16-4-3-13(8-20)9-22-16/h12-13,15-17,21-22H,3-7,9-10H2,1-2H3,(H,23,25)(H,24,26)/t12-,13?,15?,16?,17?/m1/s1
InChIKeyBIYASCUNSYMEMF-OBAOUDRSSA-N
XLogP0.20
TPSA106.05 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500359.47
LogP ≤ 50.20
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Analyze N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide?
The IUPAC name of N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide (CID 176610112) is N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide.
What is the SMILES notation for N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide?
The canonical SMILES for N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide is CC1=C(CC(=O)N[C@H](C)C2CCC(C#N)CN2)C(=O)NC2CCNCC12.
What is the InChIKey of N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide?
The InChIKey is BIYASCUNSYMEMF-OBAOUDRSSA-N. The full InChI is InChI=1S/C19H29N5O2/c1-11-14(19(26)24-17-5-6-21-10-15(11)17)7-18(25)23-12(2)16-4-3-13(8-20)9-22-16/h12-13,15-17,21-22H,3-7,9-10H2,1-2H3,(H,23,25)(H,24,26)/t12-,13?,15?,16?,17?/m1/s1.
What are the key properties of N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide?
N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide has a molecular weight of 359.47 g/mol, XLogP of 0.20, 4 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1R)-1-(5-cyanopiperidin-2-yl)ethyl]-2-(4-methyl-2-oxo-4a,5,6,7,8,8a-hexahydro-1H-1,6-naphthyridin-3-yl)acetamide is sourced from PubChem (CID 176610112), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).